New structural information about an enzyme target in cancer medicine could help the development of next generation inhibitors. The enzyme, called PARP1, senses DNA damage and sends a cellular signal to carry out repair. PARP1 activity is important to many cancer types, making it an attractive target for treatments.
Click here for original story, Researchers gain new insights into a dynamic protein targeted in cancer therapy
Source: Phys.org